2018-01-10 08:40:00 Wed ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
President Trump considers imposing retaliatory economic sanctions on Chinese products and services in direct response to China's theft and infringement of U.S. intellectual property. Trump's retaliatory trade sanctions may involve tariffs, quotas, embargoes, and other restrictions on China's investments in U.S. companies. This punitive penalty arises as part of a recent Trade Act Section 301 probe into China's recent regulations that induce U.S. multinational corporations to establish onshore IT data centers. These regulations force unfair intellectual property and technology transfer from these U.S. multinational corporations to their Chinese counterparts. Without such technology transfer, the use and implementation of U.S. patents and trademarks would otherwise involve egregious infringement at the expense of U.S. firms and other innovators.
Recent empirical evidence suggests that this unfair technology transfer may be the root cause of both billions of dollar losses in corporate revenue as well as millions of job losses in America. In addition to intellectual property theft and infringement, the Trump administration also accuses China of currency manipulation. Over the years, China has been accumulating substantial dollar reserves in the form of U.S. Treasury bonds for better renminbi devaluation. This deliberate devaluation leads to more competitive Chinese export prices and thus better low-cost product sales abroad. The Trump administration needs to consider retaliatory trade sanctions on China in order to eradicate trade deficits with better fiscal discipline.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2025-06-13 08:23:00 Friday ET

What are the mainstream legal origins of President Trump’s new tariff policies? We delve into the mainstream legal origins of President Trump&rsquo
2020-04-17 07:23:00 Friday ET

Clayton Christensen defines and delves into the core dilemma of corporate innovation with sustainable and disruptive advances. Clayton Christensen (2000)
2018-01-12 07:37:00 Friday ET

The Economist delves into the modern perils of tech titans such as Apple, Amazon, Facebook, and Google. These key tech titans often receive plaudits for mak
2018-11-15 12:35:00 Thursday ET

Warren Buffett approves Berkshire Hathaway to implement new meaningful stock repurchases. Buffett sends a positive signal to the stock market with the Berks
2017-06-21 05:36:00 Wednesday ET

In his latest Berkshire Hathaway annual letter to shareholders, Warren Buffett points out that many people misunderstand his stock investment method in seve